祖细胞
CD8型
干细胞
白细胞介素3
生物
癌症研究
效应器
细胞毒性T细胞
细胞生物学
调节器
T细胞
免疫
免疫学
白细胞介素21
免疫系统
遗传学
基因
体外
作者
Catarina Gago da Graça,Amania A. Sheikh,Dane M. Newman,Lifen Wen,S F. Li,Jian Shen,Yuqi Zhang,Sarah S. Gabriel,David Chisanga,Justine Jia Wen Seow,A Poch,L Rausch,Minh-Hanh Thi Nguyen,Jayendra Singh,C Su,Leonie A. Cluse,Carlson Tsui,Thomas N. Burn,Simone L. Park,Bianca von Scheidt
出处
期刊:Science immunology
[American Association for the Advancement of Science]
日期:2025-01-31
卷期号:10 (103)
标识
DOI:10.1126/sciimmunol.adn1945
摘要
Stem-like T cells are attractive immunotherapeutic targets in patients with cancer given their ability to proliferate and differentiate into effector progeny. Thus, identifying T cells with enhanced stemness and understanding their developmental requirements are of broad clinical and therapeutic interest. Here, we demonstrate that during acute infection, the transcriptional regulator inhibitor of DNA binding 3 (ID3) identifies stem-like T cells that are uniquely adapted to generate precursors of exhausted T (Tpex) cells in response to chronic infection or cancer. Expression of ID3 itself enables Tpex cells to sustain T cell responses in chronic infection or cancer, whereas loss of ID3 results in impaired maintenance of CD8 T cell immunity. Furthermore, we demonstrate that interleukin-1 (IL-1) family members, including IL-36β and IL-18, promote the generation of ID3 + T cells that mediate superior tumor control. Overall, we identify ID3 as a common denominator of stem-like T cells in both acute and chronic infections that is specifically required to sustain T cell responses to chronic stimulation.
科研通智能强力驱动
Strongly Powered by AbleSci AI